• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CAR T-cell therapy-paving the way for sensitized kidney transplant patients.

作者信息

Jarmi Tambi, Luo Yan, Attieh Rose Mary, Qie Yaqing, Gadd Martha E, Hundal Tanya, Mao Shennen, Murthy Hemant S, Taner Burcin C, Kharfan-Dabaja Mohamed A, Qin Hong

机构信息

Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA.

Regenerative Immunotherapy and CAR-T Translational Research Program, Mayo Clinic, Jacksonville, Florida, USA; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, USA.

出版信息

Kidney Int. 2024 May;105(5):1124-1129. doi: 10.1016/j.kint.2024.02.008. Epub 2024 Apr 2.

DOI:10.1016/j.kint.2024.02.008
PMID:38573274
Abstract
摘要

相似文献

1
CAR T-cell therapy-paving the way for sensitized kidney transplant patients.嵌合抗原受体T细胞疗法——为致敏肾移植患者铺平道路。
Kidney Int. 2024 May;105(5):1124-1129. doi: 10.1016/j.kint.2024.02.008. Epub 2024 Apr 2.
2
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case Report.抗CD19嵌合抗原受体T细胞疗法治疗伴有11q畸变的难治性侵袭性伯基特样淋巴瘤后发生的肾移植T细胞介导的排斥反应：一例报告
Am J Kidney Dis. 2022 May;79(5):760-764. doi: 10.1053/j.ajkd.2021.07.012. Epub 2021 Aug 27.
3
Safety of CAR T-cell therapy in kidney transplant recipients.肾移植受者中CAR T细胞疗法的安全性。
Blood. 2021 May 6;137(18):2558-2562. doi: 10.1182/blood.2020008759.
4
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.实体器官移植后移植后淋巴细胞增殖性疾病的嵌合抗原受体T细胞疗法：一种针对罕见病的安全可行的疗法。
Clin Lymphoma Myeloma Leuk. 2023 Oct;23(10):772-778. doi: 10.1016/j.clml.2023.05.007. Epub 2023 May 12.
5
Chimeric antigen receptor T (CAR T) cells: another cancer therapy with potential applications in kidney disease and transplantation?嵌合抗原受体T（CAR T）细胞：另一种在肾脏疾病和移植中具有潜在应用的癌症疗法？
Kidney Int. 2018 Jul;94(1):4-6. doi: 10.1016/j.kint.2018.05.006.
6
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.临床级制备条件下靶向 BAFF-R 的 CAR T 细胞的抗肿瘤疗效。
Cancer Immunol Immunother. 2020 Oct;69(10):2139-2145. doi: 10.1007/s00262-020-02614-8. Epub 2020 May 25.
7
Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.嵌合抗原受体 T 细胞疗法治疗实体器官移植受者淋巴瘤的疗效和毒性：系统评价和荟萃分析。
Transplant Cell Ther. 2024 Jan;30(1):73.e1-73.e12. doi: 10.1016/j.jtct.2023.05.018. Epub 2023 Jun 4.
8
How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?如何将两种标志性治疗方法——异体造血干细胞移植和嵌合抗原受体 T 细胞疗法相结合，治愈高危 B 细胞急性淋巴细胞白血病？
Front Immunol. 2020 Dec 15;11:611710. doi: 10.3389/fimmu.2020.611710. eCollection 2020.
9
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.嵌合抗原受体 T 细胞靶向 BAFF-R 可以克服 B 细胞恶性肿瘤中 CD19 抗原的丢失。
Sci Transl Med. 2019 Sep 25;11(511). doi: 10.1126/scitranslmed.aaw9414.
10
Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.嵌合抗原受体 T 细胞治疗后急性肾损伤：发生率低且恢复迅速。
Biol Blood Marrow Transplant. 2020 Jun;26(6):1071-1076. doi: 10.1016/j.bbmt.2020.02.012. Epub 2020 Feb 20.

引用本文的文献

1
Nephrology's Next Frontier: Expanding the Reach of CAR T-Cell Therapy for Refractory Lupus Nephritis and Beyond.肾脏病学的下一个前沿领域：扩大嵌合抗原受体T细胞疗法在难治性狼疮性肾炎及其他疾病中的应用范围
Indian J Nephrol. 2025 Jul-Aug;35(4):456-459. doi: 10.25259/IJN_274_2024. Epub 2024 Dec 11.
2
Desensitization in HLA-incompatible kidney transplant recipients: current strategies and emerging perspectives.HLA不相合肾移植受者的脱敏治疗：当前策略与新观点
Clin Kidney J. 2025 Jul 9;18(8):sfaf219. doi: 10.1093/ckj/sfaf219. eCollection 2025 Aug.
3
Recent advances in treatment options for kidney disease.
肾病治疗方案的最新进展。
Curr Opin Nephrol Hypertens. 2025 Sep 1;34(5):347-349. doi: 10.1097/MNH.0000000000001100. Epub 2025 Jul 31.
4
Diverse potential of chimeric antigen receptor-engineered cell therapy: Beyond cancer.嵌合抗原受体工程细胞疗法的多样潜力：超越癌症。
Clin Transl Med. 2025 Apr;15(4):e70306. doi: 10.1002/ctm2.70306.
5
Donor-Specific Blood Transfusion in Lung Transplantation.肺移植中的供者特异性输血。
Transpl Int. 2024 Oct 30;37:12822. doi: 10.3389/ti.2024.12822. eCollection 2024.
6
Application of novel CAR technologies to improve treatment of autoimmune disease.新型 CAR 技术在改善自身免疫性疾病治疗中的应用。
Front Immunol. 2024 Oct 9;15:1465191. doi: 10.3389/fimmu.2024.1465191. eCollection 2024.